Delaware
|
001-34912
|
22-2711928
|
(State or other Jurisdiction of Incorporation or Organization)
|
(Commission File Number)
|
(I.R.S. Employer Identification No.)
|
Large accelerated filer
|
☒ |
Accelerated filer
|
☐ |
Non-accelerated filer
|
☐ |
Smaller reporting company
|
☐ |
Emerging growth company
|
☐
|
• |
Registration Statement No. 333-223469, registering 20,403,384 common shares, par value $0.01 per share (the “Common Stock”), of Celgene Corporation (“Celgene”) for the Celgene Corporation 2014 Equity Incentive Plan (F/K/A Juno Therapeutics, Inc. 2014 Equity Incentive Plan).
|
• |
Registration Statement No. 333-219505, registering 10,000,000 shares of Common Stock for the Celgene Corporation 2017 Stock Incentive Plan (F/K/A Celgene Corporation 2008 Stock Incentive Plan,
Celgene Corporation 1998 Stock Incentive Plan and Celgene Corporation 1998 Long-Term Incentive Plan).
|
• |
Registration Statement No. 333-212728, registering 17,500,000 shares of Common Stock for the Celgene Corporation 2017 Stock Incentive Plan (F/K/A Celgene Corporation 2008 Stock Incentive Plan,
Celgene Corporation 1998 Stock Incentive Plan and Celgene Corporation 1998 Long-Term Incentive Plan).
|
• |
Registration Statement No. 333-207840, registering 19,800,000 shares of Common Stock for the Celgene Corporation 2017 Stock Incentive Plan (F/K/A Celgene Corporation 2008 Stock Incentive Plan,
Celgene Corporation 1998 Stock Incentive Plan and Celgene Corporation 1998 Long-Term Incentive Plan).
|
• |
Registration Statement No. 333-199638, registering 18,000,000 shares of Common Stock for the Celgene Corporation 2017 Stock Incentive Plan (F/K/A Celgene Corporation 2008 Stock Incentive Plan,
Celgene Corporation 1998 Stock Incentive Plan and Celgene Corporation 1998 Long-Term Incentive Plan).
|
• |
Registration Statement No. 333-191996, registering 9,000,000 shares of Common Stock for the Celgene Corporation 2017 Stock Incentive Plan (F/K/A Celgene Corporation 2008 Stock Incentive Plan, Celgene
Corporation 1998 Stock Incentive Plan and Celgene Corporation 1998 Long-Term Incentive Plan).
|
• |
Registration Statement No. 333-184634, registering 14,000,000 shares of Common Stock for the Celgene Corporation 2017 Stock Incentive Plan (F/K/A Celgene Corporation 2008 Stock Incentive Plan,
Celgene Corporation 1998 Stock Incentive Plan and Celgene Corporation 1998 Long-Term Incentive Plan).
|
• |
Registration Statement No. 333-177669, registering 11,200,000 shares of Common Stock for the Celgene Corporation 2017 Stock Incentive Plan (F/K/A Celgene Corporation 2008 Stock Incentive Plan,
Celgene Corporation 1998 Stock Incentive Plan and Celgene Corporation 1998 Long-Term Incentive Plan).
|
• |
Registration Statement No. 333-160955, registering 18,409,450 shares of Common Stock for the Celgene Corporation 2017 Stock Incentive Plan (F/K/A Celgene Corporation 2008 Stock Incentive Plan,
Celgene Corporation 1998 Stock Incentive Plan and Celgene Corporation 1998 Long-Term Incentive Plan).
|
• |
Registration Statement No. 333-152655, registering 10,155,135 shares of Common Stock for the Celgene Corporation 2017
Stock Incentive Plan (F/K/A Celgene Corporation 2008 Stock Incentive Plan, Celgene Corporation 1998 Stock Incentive Plan and Celgene Corporation 1998 Long-Term Incentive Plan).
|
• |
Registration Statement No. 333-149603, registering 1,225,000 shares of Common Stock for the Pharmion Corporation 2000
Stock Incentive Plan.
|
• |
Registration Statement No. 333-138497, registering 22,000,000 shares of Common Stock for the Celgene Corporation 2017 Stock Incentive Plan (F/K/A Celgene
Corporation 2008 Stock Incentive Plan, Celgene Corporation 1998 Stock Incentive Plan and Celgene Corporation 1998 Long-Term Incentive Plan).
|
• |
Registration Statement No. 333-126296, registering 6,000,000 shares of Common Stock for the Celgene Corporation 2017 Stock Incentive Plan (F/K/A Celgene Corporation 2008 Stock Incentive Plan, Celgene
Corporation 1998 Stock Incentive Plan and Celgene Corporation 1998 Long-Term Incentive Plan).
|
• |
Registration Statement No. 333-107980, registering 4,137,031 shares of Common Stock for the Celgene Corporation 2017 Stock Incentive Plan (F/K/A Celgene
Corporation 2008 Stock Incentive Plan, Celgene Corporation 1998 Stock Incentive Plan and Celgene Corporation 1998 Long-Term Incentive Plan) and the Anthrogenesis Corporation Qualified Employee Incentive Stock Option Plan.
|
• |
Registration Statement No. 333-65908, registering 2,000,000 shares of Common Stock for the Celgene Corporation 2017 Stock Incentive Plan (F/K/A Celgene Corporation 2008 Stock Incentive Plan, Celgene
Corporation 1998 Stock Incentive Plan and Celgene Corporation 1998 Long-Term Incentive Plan).
|
• |
Registration Statement No. 333-39716, registering 2,000,000 shares of Common Stock for the Celgene Corporation 2017 Stock Incentive Plan (F/K/A Celgene Corporation 2008 Stock Incentive Plan, Celgene
Corporation 1998 Stock Incentive Plan and Celgene Corporation 1998 Long-Term Incentive Plan).
|
• |
Registration Statement No. 333-91977, registering 1,000,000 shares of Common Stock for the Celgene Corporation 1992 Long-Term Incentive Plan and the Celgene Corporation 1995 Non-Employee Directors’
Incentive Plan.
|
• |
Registration Statement No. 333-70083, registering 1,890,000 shares of Common Stock for the Celgene Corporation 2017 Stock Incentive Plan (F/K/A Celgene Corporation 2008 Stock Incentive Plan, Celgene
Corporation 1998 Stock Incentive Plan and Celgene Corporation 1998 Long-Term Incentive Plan) and the Non-Plan Stock Option Agreements.
|
Celgene Corporation
|
||
/s/ Katherine R. Kelly
|
||
By:
|
Katherine R. Kelly
|
|
Title:
|
Secretary
|